David Graham, an FDA drug safety researcher who played a key role in the Vioxx saga, published astudycomparing Avandia to its main competitor, Actos, in a quarter of a million Medicare patients.
Today the New England Journal of Medicine has published a Spanish studycomparing two versions of the Mediterranean diet with a low fat diet and the result is important news if you are interested in reducing your risk of heart disease and stroke.